Investing
Proceeds from Sales of Assets and Subsidiaries
Johnson & Johnson Proceeds from Sales of Assets and Subsidiaries decreased by 90.7% to $29.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 89.6%, from $279.00M to $29.00M. Over 4 years (FY 2021 to FY 2025), Proceeds from Sales of Assets and Subsidiaries shows relatively stable performance with a 0.3% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
First reportedQ1 2007
Last reportedQ1 2026Apr 22, 2026
Metric ID:
c_proceeds_from_sale_of_assets_and_subsidiariesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $51.00M | $12.00M | $45.00M | $248.00M | $66.00M | $8.00M | $221.00M | $40.00M | $76.00M | $121.00M | $121.00M | $210.00M | $363.00M | $50.00M | $52.00M | $279.00M | $53.00M | $76.00M | $312.00M | $29.00M |
| QoQ Change | — | -76.5% | +275.0% | +451.1% | -73.4% | -87.9% | >999% | -81.9% | +90.0% | +59.2% | +0.0% | +73.6% | +72.9% | -86.2% | +4.0% | +436.5% | -81.0% | +43.4% | +310.5% | -90.7% |
| YoY Change | — | — | — | — | +29.4% | -33.3% | +391.1% | -83.9% | +15.2% | >999% | -45.2% | +425.0% | +377.6% | -58.7% | -57.0% | +32.9% | -85.4% | +52.0% | +500.0% | -89.6% |
Range$8.00M – $363.00M
CAGR-11.2%
Avg YoY Growth+173.9%
Median YoY Growth+22.3%
Proceeds from Sales of Assets and Subsidiaries at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's proceeds from sales of assets and subsidiaries?
- Johnson & Johnson (JNJ) reported proceeds from sales of assets and subsidiaries of $29.00M in Q1 2026.
- How has Johnson & Johnson's proceeds from sales of assets and subsidiaries changed year-over-year?
- Johnson & Johnson's proceeds from sales of assets and subsidiaries decreased by 89.6% year-over-year, from $279.00M to $29.00M.
- What is the long-term trend for Johnson & Johnson's proceeds from sales of assets and subsidiaries?
- Over 4 years (2021 to 2025), Johnson & Johnson's proceeds from sales of assets and subsidiaries has grown at a 0.3% compound annual growth rate (CAGR), from $711.00M to $720.00M.